Cor Therapeutics Inc. (CORR) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cor Therapeutics Inc. (CORR)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John Patterson who wrote (248)	7/28/1998 11:06:00 PM
From: aknahow	Read Replies (1) of 712

I was disappointed that Merck raised their dividend and announced a share buy-back but, in time redeployment of their resources will have an impact on biotecks. Did you see the press release from the Informed Investors conference showing the value of Merck being many billions more more than 180 biotech companies which have many more products in clinical trials? Have written a few Oct. puts on CORR @ $12.5. I would not mind owning at this price less the premium. They were done a month or so ago when the market price was lower and the time premium higher. CORR has been a strange story. My only involvement has been with selling puts and covered calls. Never expected to be able to start the whole process all over.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next